AnaptysBio Q2 Net Income USD 183.88 Million
AnaptysBio Q2 operating expenses were USD 13.34 million. Q2 collaboration revenue was USD 27.488 million and Q2 income from operations was USD 14.148 million.
AnaptysBio Q2 operating expenses were USD 13.34 million. Q2 collaboration revenue was USD 27.488 million and Q2 income from operations was USD 14.148 million.